Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Graham

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 21, 2018
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief ReportFeiming Ye, Ya Wang, Congqing Wu, et al.
Nucleic Acids Research|September 22, 2017
Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levelsXue-Hai Liang, Hong Sun, Wen Shen, et al.
Nature Communications|April 8, 2015
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosisJi Miao, Alisha V Ling, Praveen V Manthena, et al.
Cell Metabolism|March 27, 2018
γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL ReceptorKyeongJin Kim, Ira J Goldberg, Mark J Graham, et al.
Plos One|January 10, 2014
Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic miceStephanie M Marshall, Kathryn L Kelley, Matthew A Davis, et al.
Lancet (London, England)|July 27, 2015
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 studySotirios Tsimikas, Nicholas J Viney, Steven G Hughes, et al.
Diabetes Care|June 9, 2016
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 DiabetesAndres Digenio, Richard L Dunbar, Veronica J Alexander, et al.
Plos One|June 6, 2014
Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretionStephanie M Marshall, Anthony D Gromovsky, Kathryn L Kelley, et al.
Circulation Research|January 12, 2018
Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL ReceptorDebapriya Basu, Yunying Hu, Lesley-Ann Huggins, et al.
Mediators of Inflammation|May 8, 2014
Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent modelsAlexander J Szalai, Mark A McCrory, Dongqi Xing, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Arteriosclerosis, Thrombosis, and Vascular Biology|December 21, 2018
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief ReportFeiming Ye, Ya Wang, Congqing Wu, et al.
Nucleic Acids Research|September 22, 2017
Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levelsXue-Hai Liang, Hong Sun, Wen Shen, et al.
Nature Communications|April 8, 2015
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosisJi Miao, Alisha V Ling, Praveen V Manthena, et al.
Cell Metabolism|March 27, 2018
γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL ReceptorKyeongJin Kim, Ira J Goldberg, Mark J Graham, et al.
Plos One|January 10, 2014
Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic miceStephanie M Marshall, Kathryn L Kelley, Matthew A Davis, et al.
Lancet (London, England)|July 27, 2015
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 studySotirios Tsimikas, Nicholas J Viney, Steven G Hughes, et al.
Diabetes Care|June 9, 2016
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 DiabetesAndres Digenio, Richard L Dunbar, Veronica J Alexander, et al.
Plos One|June 6, 2014
Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretionStephanie M Marshall, Anthony D Gromovsky, Kathryn L Kelley, et al.
Circulation Research|January 12, 2018
Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL ReceptorDebapriya Basu, Yunying Hu, Lesley-Ann Huggins, et al.
Mediators of Inflammation|May 8, 2014
Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent modelsAlexander J Szalai, Mark A McCrory, Dongqi Xing, et al.
Pageof 14